Stability of cytokines in supernatants of stimulated mouse immune cells

European Cytokine Network

Volumn 25, Issue 2, 2014, Pages 30-34

  Ozbey, G ^a   Gorczynski, R ^b   Erin, N ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Cytokines; ELISA; Secrotomes; Stability

Indexed keywords

CXCL2 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6; PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; CONCANAVALIN A; CXCL2 PROTEIN, MOUSE; INTERLEUKIN DERIVATIVE; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FREEZE THAWING; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY; SENSITIVITY AND SPECIFICITY; STIMULATION; SUPERNATANT; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CHEMISTRY; DRUG EFFECTS; FREEZING; IMMUNOLOGY; LYMPH NODE; LYMPHOCYTE; PATHOLOGY; SECRETION (PROCESS); SPLEEN; TUMOR CELL CULTURE;

ANIMALS; CHEMOKINE CXCL2; CONCANAVALIN A; FEMALE; FREEZING; INTERFERON-GAMMA; INTERLEUKINS; LIPOPOLYSACCHARIDES; LYMPH NODES; LYMPHOCYTES; MICE; MICE, INBRED BALB C; PROTEIN STABILITY; REFRIGERATION; SPLEEN; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84925883639     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2014.0353     Document Type: Article

References (20)

1. Meager A. Measurement of cytokines by bioassays: theory and application. Methods 2006; 38: 237.
2. Chu WM. Tumor necrosis factor. Cancer Lett 2013; 328: 222.
3. Saha B, Jyothi Prasanna S, Chandrasekar B, Nandi D. Gene modulation and immunoregulatory roles of interferon gamma. Cytokine 2010; 50: 1.
4. Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol 2011; 29: 71.
5. Nishimoto N. Interleukin-6 as a therapeutic target in candidate inflammatory diseases. Clin Pharmacol Ther 2010; 87: 483.
6. Zhu S, Qian Y. IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential. Clin Sci (Lond) 2012; 122: 487.
7. Acharyya S, Oskarsson T, Vanharanta S, Malladi S, Kim J, Morris PG, Manova-Todorova K, Leversha M, Hogg N, Seshan VE, Norton L, Brogi E, Massague J. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell 2012; 150: 165.
8. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140: 883.
9. Yamaguchi Y, Ohshita A, Kawabuchi Y, Ohta K, Shimizu K, Minami K, Hihara J, Miyahara E, Toge T. Adoptive immunotherapy of cancer using activated autologous lymphocytes-current status and new strategies. Hum Cell 2003; 16: 183.
10. House RV. Cytokine measurement techniques for assessing hypersensitivity. Toxicology 2001; 158: 51.
11. Keustermans GC, Hoeks SB, Meerding JM, Prakken BJ, de Jager W. Cytokine assays: an assessment of the preparation and treatme nt ofblood and tissue samples. Methods 2013; 61: 10.
12. De Jongh R, Vranken J, Vundelinckx G, Bosmans E, Maes M, Heylen R. The effects of anticoagulation and processing on assays of IL-6, sIL-6R, sIL-2R and soluble transferrin receptor. Cytokine 1997; 9: 696.
13. Flower L, Ahuja RH, Humphries SE, Mohamed-Ali V. Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin. Cytokine 2000; 12: 1712.
14. Kenis G, Teunissen C, De Jongh R, Bosmans E, Steinbusch H, Maes M. Stability of interleukin 6, soluble interleukin 6 receptor, interleukin 10 and CC16 in human serum. Cytokine 2002; 19: 228.
15. Erin E, Kale S, Tanriover G, Koksoy S, Duymus O, Korcum AF. Differential characteristics of heart, liver, and brain metastatic subsets of murine breast carcinoma. Breast Cancer Res Treat 2013; 139: 677.
16. Moehrlen U, Lechner A, Baumel M, Dostert K, Rohrl J, Meuli M, Mannel DN, Hamacher J. Immune cell populations and cytokine production in spleen and mesenteric lymph nodes after laparoscopic surgery versus conventional laparotomy in mice. Pediatr Surg Int 2012; 28: 507.
17. Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godfroid J, Walravens K, Letesson JJ. Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp. Infect Immun 2001; 69: 6264.
18. de Jager W, Bourcier K, Rijkers GT, Prakken BJ, Seyfert-Margolis V. Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol 2009; 28: 10.
19. Friebe A, Volk HD. Stability of tumor necrosis factor alpha, interleukin 6, and interleukin 8 in blood samples of patients with systemic immune activation. Arch Pathol Lab Med 2008; 132: 1802.
20. Erin N, Ulusoy O. Differentiation of neuronal from non-neuronal Substance P. Regul Pept 2009; 152: 108.